EF

Elena Feinstein

QP Quark Pharmaceuticals: 56 patents #1 of 40Top 3%
ND Nitto Denko: 8 patents #411 of 2,479Top 20%
QB Quark Biotech: 5 patents #3 of 23Top 15%
HD Hadasit Medical Research Services And Development: 4 patents #22 of 373Top 6%
CB Cleveland Biolabs: 3 patents #5 of 7Top 75%
IB Insight Biopharmaceuticals: 3 patents #5 of 18Top 30%
ST Sapience Therapeutics: 3 patents #15 of 30Top 50%
WU Washington University: 2 patents #386 of 1,596Top 25%
FC Fujisawa Pharmaceutical Co.: 1 patents #444 of 782Top 60%
RJ Rutgers, The State University Of New Jersey: 1 patents #651 of 1,498Top 45%
SC Shionogi & Co.: 1 patents #620 of 1,054Top 60%
CC Cleveland Clinic: 1 patents #483 of 972Top 50%
IM Insight Strategy & Marketing: 1 patents #13 of 23Top 60%
📍 Rehovot, NY: #1 of 11 inventorsTop 10%
Overall (All Time): #24,475 of 4,157,543Top 1%
77
Patents All Time

Issued Patents All Time

Showing 51–75 of 77 patents

Patent #TitleCo-InventorsDate
8309532 Therapeutic uses of inhibitors of RTP801 Jörg Kaufmann, Klaus Giese 2012-11-13
8278287 siRNA compounds for inhibiting NRF2 Igor Mett, Hagar Kalinski 2012-10-02
8198258 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases Orna Mor 2012-06-12
8168607 Methods of treating eye diseases in diabetic patients Jörg Kaufmann, Klaus Giese 2012-05-01
8148342 Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases Shai Ehrlich 2012-04-03
8067570 Therapeutic uses of inhibitors of RTP801 Rami Skaliter 2011-11-29
8034575 Screening systems utilizing RTP801 Roni Wechsler, Igor Mett 2011-10-11
8017764 Therapeutic uses of inhibitors of RTP801L Igor Mett 2011-09-13
7939652 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases Orna Mor 2011-05-10
7910566 Prevention and treatment of acute renal failure and other kidney diseases by inhibition of p53 by siRNA 2011-03-22
7872119 Inhibitors of RTP801 and their use in disease treatment Rami Skaliter 2011-01-18
7842674 Methods of treatment of acute renal failure Shai Ehrlich 2010-11-30
7825099 Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes 2010-11-02
7812002 Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer 2010-10-12
7741299 Therapeutic uses of inhibitors of RTP801 Jörg Kaufmann, Klaus Giese 2010-06-22
7666651 Polypeptide having heparanase activity Iris Pecker, Israel Vlodavsky 2010-02-23
7626015 Therapeutic uses of inhibitors of RTP801L Igor Mett 2009-12-01
7524935 Sequences characteristic of hypoxia-regulated gene transcription Paz Einat, Rami Skaliter, Aviv Regev, Hagar Kalinski 2009-04-28
7259253 Genes associated with mechanical stress, expression products therefrom, and uses thereof Paz Einat, Orit Segev, Rami Skaliter, Alexander Faerman, Aviva Samach 2007-08-21
7074895 Sequences characteristic of hypoxia-regulated gene transcription Paz Einat, Rami Skaliter, Aviv Regev 2006-07-11
6998232 Methods of diagnosing bladder cancer Orna Mor 2006-02-14
6960471 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells Iris Pecker, Israel Vlodavsky 2005-11-01
6833237 Genes involved in stroke response and/or regulated by FK506, proteins encoded thereby, and methods of use Igor Mett, Sylvia Kachalsky, Svetlana Gorodin 2004-12-21
6790658 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells Iris Pecker, Israel Vlodavsky 2004-09-14
6696454 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation Dganit Bar, Orit Segev 2004-02-24